Patrick Baron

Patrick Baron is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as a Key-Account-Manager for Rare Diseases at Horizon since February 2022. Previously, Patrick held various managerial roles, including Regionalleiter Spezialaußendienst at AbbVie and Regionalmanager D-A-CH at Orchard Therapeutics, specializing in ex-vivo gene therapies. Patrick's experience also includes key-account management at Biogen, focusing on spinal muscular atrophy, and positions at AbbVie and Teva GmbH, where expertise spanned hematology, oncology, and pain management. Educational qualifications include a degree as a Chemisch Technischer Assistent from Naturwissenschaftliches Technikum Dr Künkele.